Skip to content
Open access

Experimental Evidence for HIV-Associated Phenotypic Reprogramming of CD4□ T Cells: An Exploratory Immunological Study

Jul 2026 · bioRxiv · 0 citations · 47 references
Biology

TL;DR

Findings support the hypothesis that chronic HIV infection may be associated with phenotypic reprogramming of CD4□ T cells rather than simple quantitative depletion alone and provide an alternative framework for investigating HIV-associated immune dysfunction.

Read PDF

Similar papers

Open access Aug 2026

Age and CMV are not associated with clinical or immunological response to immune checkpoint blockade

Ageing and cytomegalovirus (CMV) infection drive major alterations to T-cell immunity. Age is also associated with an increased risk of cancers including melanoma, which is treated with T-cell modifying immune checkpoint blockade (ICB). However, the extent to which age, CMV, and treatment-induced immune changes interac...

J. M. Edwards, S. Senthi, R. Smith et al. · 0 citations
#protein folding Open access Sep 2026

STING-mediated JAK-STAT suppression drives CD4⁺ T cell dysfunction in aging people living with HIV-1

STING-mediated JAK-STAT suppression is identified as a novel mechanism of immune dysfunction in aging PLWH, proposing targeted STING inhibition as a potential therapeutic strategy to improve immune recovery in this vulnerable population.

Na Li, Hong-Yi Zheng, Xia Li et al. · 0 citations
Open access Aug 2026

PD-1 regulates CD4+ T cell-mediated CD8+ T cell responses in the brain to balance viral control and neuroinflammation

Programmed cell death protein 1 (PD-1) is expressed by T cells during progressive multifocal leukoencephalopathy (PML), a life-threatening brain disease caused by the human-only JC polyomavirus (JCPyV). PD-1 checkpoint immunotherapy has benefited some PML patients, but reasons for its variable outcomes are unclear. Usi...

Arrienne B. Butic, E. Afanasiev, Samantha A. Spencer et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.